The use of OKT3 in steroid-resistant rejections following cadaveric kidney transplantation.
OKT3 has been proved to be effective in the treatment of steroid-resistant rejection after renal allograft transplantation. We investigated the clinical course of OKT3 recipients to find out in which cases of steroid resistance OKT3 therapy might be ineffective.
Rosenkranz
B
B
Department for General Surgery, University Hospitals, D-4300 Essen, FRG.
Niebel
W
W
Albrecht
K
K
Wagner
K
K
Philipp
T
T
Eigler
F W
FW
D000328:Adult; D000818:Animals; D002102:Cadaver; D005260:Female; D006084:Graft Rejection / Q000517:prevention & control*; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality / Q000473:pathology; D008297:Male; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D013256:Steroids / Q000009:adverse effects*; D016019:Survival Analysis; D013997:Time Factors; D014019:Tissue Donors
D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D013256:Steroids